Provectus Biopharmaceuticals, Inc.
PVCT
$0.0799
-$0.0024-2.92%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 385.90K | 390.40K | 307.40K | 187.50K | 29.60K |
| Total Receivables | -- | -- | -- | -- | 800.00 |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 147.40K | 175.60K | 487.00K | 145.80K | 210.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 34.90K | 83.40K | 182.30K | 426.70K | 559.70K |
| Total Current Assets | 568.30K | 649.50K | 976.80K | 760.00K | 800.20K |
|
|
|||||
| Total Current Assets | 568.30K | 649.50K | 976.80K | 760.00K | 800.20K |
| Net Property, Plant & Equipment | 154.10K | 16.80K | 29.50K | 42.00K | 56.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 722.40K | 666.30K | 1.01M | 802.00K | 856.40K |
|
|
|||||
| Total Accounts Payable | 1.31M | 744.00K | 1.11M | 1.38M | 1.32M |
| Total Accrued Expenses | 2.77M | 2.36M | 2.35M | 1.69M | 3.54M |
| Short-term Debt | 54.30K | 124.60K | 206.50K | 110.50K | 109.90K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.36M | 2.45M | 2.98M | 2.69M | 2.94M |
| Total Finance Division Other Current Liabilities | -- | 57.50K | 336.10K | 350.40K | 460.20K |
| Total Other Current Liabilities | -- | 57.50K | 336.10K | 350.40K | 460.20K |
| Total Current Liabilities | 6.49M | 5.74M | 6.98M | 6.22M | 8.37M |
|
|
|||||
| Total Current Liabilities | 6.49M | 5.74M | 6.98M | 6.22M | 8.37M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 54.30K | 124.60K | 206.50K | 110.50K | 109.90K |
| Capital Leases | 103.90K | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.60M | 5.74M | 6.98M | 6.22M | 8.37M |
|
|
|||||
| Common Stock & APIC | 254.55M | 253.51M | 251.51M | 249.68M | 246.58M |
| Retained Earnings | -260.38M | -258.56M | -257.42M | -255.06M | -254.04M |
| Treasury Stock & Other | -60.40K | -60.70K | -60.70K | -60.20K | -60.50K |
| Total Common Equity | -5.89M | -5.12M | -5.97M | -5.44M | -7.53M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 14.70K | 14.40K | 14.10K | 14.00K | 13.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 14.70K | 14.40K | 14.10K | 14.00K | 13.00K |
|
|
|||||
| Total Common Equity | -5.89M | -5.12M | -5.97M | -5.44M | -7.53M |
| Total Preferred Equity | 14.70K | 14.40K | 14.10K | 14.00K | 13.00K |
| Total Minority Interest | -3.80K | 33.80K | -9.90K | -- | -- |
| Total Equity | -5.87M | -5.07M | -5.97M | -5.42M | -7.51M |
|
|
|||||